Epiberberine attenuates diabetic atherosclerosis by inhibiting the Raf/MEK1/2/ERK1/2 pathway

Guan Wang, Yanan Zhao, Xiaoshan Zhang, Yu Zhang, Xinyi Zhang
International Immunopharmacology · Elsevier · DOI: 10.1016/j.intimp.2026.117664

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles